Patents by Inventor John Erich Oblong

John Erich Oblong has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230165778
    Abstract: Disclosed is a method of improving the appearance of skin with a low-pH skin care composition that contains hydroxycinnamic acid (HCA) and a vitamin B3 compound in a synergistic combination.
    Type: Application
    Filed: November 29, 2022
    Publication date: June 1, 2023
    Inventors: Matthew Clair Ehrman, Tomohiro Hakozaki, John Erich Oblong, DISSANAYAKE MUDIYANSELAGE MAHATHMA BANDARA DISSANAYAKE, Wan Ting Chung
  • Patent number: 11137387
    Abstract: A method of identifying or evaluating synergistic combinations of actives such as skin-care actives that improve the metabolism of a cell and provides an advantage over using the actives alone. The method includes contacting cells with test agents, alone and in combination, and determining a response of the cells to the test agent(s), wherein the response corresponds to a change in a metabolic indicator associated with glycolysis and a change in a metabolic indicator associated with oxidative phosphylation.
    Type: Grant
    Filed: June 29, 2017
    Date of Patent: October 5, 2021
    Assignee: The Procter & Gamble Company
    Inventors: John Erich Oblong, Holly Ann Rovito
  • Patent number: 11110049
    Abstract: Low pH cosmetic compositions and methods for improving the appearance of skin. The low pH cosmetic compositions herein include a saccharide and, optionally, one or more additional skin care actives to improve the appearance of skin. The lower pH reduces or even eliminates some of the skin health and appearance drawbacks associated with saccharide induced glycation.
    Type: Grant
    Filed: April 28, 2020
    Date of Patent: September 7, 2021
    Assignee: The Procter & Gamble Company
    Inventors: Tomohiro Hakozaki, John Erich Oblong, Bin Fang Deyer
  • Patent number: 11013678
    Abstract: A skin care product is provided. The skin care product includes a multi-component skin care composition disposed in a multi-chamber container. The multi-component skin care composition includes an aqueous carrier component and a nicotinamide riboside component disposed in separate chambers, which prevents these components from contacting one another prior to use. The aqueous carrier component and the nicotinamide riboside component can be separated from one another by one or more fluid impermeable dividing members and/or activatable elements, which upon activation enable contact between the aqueous carrier component and nicotinamide riboside component.
    Type: Grant
    Filed: June 29, 2016
    Date of Patent: May 25, 2021
    Assignee: The Procter & Gamble Company
    Inventors: Tomohiro Hakozaki, John Erich Oblong, Jesus Velazquez
  • Publication number: 20200253851
    Abstract: Low pH cosmetic compositions and methods for improving the appearance of skin. The low pH cosmetic compositions herein include a saccharide and, optionally, one or more additional skin care actives to improve the appearance of skin. The lower pH reduces or even eliminates some of the skin health and appearance drawbacks associated with saccharide induced glycation.
    Type: Application
    Filed: April 28, 2020
    Publication date: August 13, 2020
    Inventors: Tomohiro NMN HAKOZAKI, John Erich OBLONG, Bin NMN FANG DEYER
  • Patent number: 10660838
    Abstract: Low pH cosmetic compositions and methods for improving the appearance of skin. The low pH cosmetic compositions herein include a saccharide and, optionally, one or more additional skin care actives to improve the appearance of skin. The lower pH reduces or even eliminates some of the skin health and appearance drawbacks associated with saccharide induced glycation.
    Type: Grant
    Filed: June 22, 2018
    Date of Patent: May 26, 2020
    Assignee: The Procter & Gamble Company
    Inventors: Tomohiro Hakozaki, John Erich Oblong, Bin Fang Deyer
  • Patent number: 10302630
    Abstract: A method of identifying or evaluating skin-care actives that improve the metabolism of a skin cell. The method includes contacting cells with a stressor and a test agent and determining a response of the cells to the stressor and test agent, based on the change in metabolic indicators associated with glycolysis and/or oxidative phosphylation. The test agent may be identified as a skin-care active when the oxidative phosphorylation and/or glycolysis response corresponds to an improvement in cellular metabolism.
    Type: Grant
    Filed: October 9, 2013
    Date of Patent: May 28, 2019
    Assignee: The Procter & Gamble Company
    Inventors: John Erich Oblong, Holly Ann Rovito
  • Publication number: 20180369110
    Abstract: Low pH cosmetic compositions and methods for improving the appearance of skin. The low pH cosmetic compositions herein include a saccharide and, optionally, one or more additional skin care actives to improve the appearance of skin. The lower pH reduces or even eliminates some of the skin health and appearance drawbacks associated with saccharide induced glycation.
    Type: Application
    Filed: June 22, 2018
    Publication date: December 27, 2018
    Inventors: Tomohiro HAKOZAKI, John Erich OBLONG, Bin FANG DEYER
  • Patent number: 9833398
    Abstract: Cosmetic methods and compositions for improving the appearance and barrier function of skin. The methods and compositions utilize a combination of niacinamide and a suitable saccharide at low pH to decrease trans-epidermal water loss in skin, reduce the size of hyperpigmented spots, and improve the appearance of skin better than their high pH counterparts.
    Type: Grant
    Filed: January 10, 2017
    Date of Patent: December 5, 2017
    Assignee: The Procter & Gamble Company
    Inventors: Tomohiro Hakozaki, John Erich Oblong
  • Publication number: 20170299577
    Abstract: A method of identifying or evaluating synergistic combinations of actives such as skin-care actives that improve the metabolism of a cell and provides an advantage over using the actives alone. The method includes contacting cells with test agents, alone and in combination, and determining a response of the cells to the test agent(s), wherein the response corresponds to a change in a metabolic indicator associated with glycolysis and a change in a metabolic indicator associated with oxidative phosphylation.
    Type: Application
    Filed: June 29, 2017
    Publication date: October 19, 2017
    Inventors: John Erich OBLONG, Holly Ann ROVITO
  • Patent number: 9726663
    Abstract: A method of identifying or evaluating synergistic combinations of actives such as skin-care actives that improve the metabolism of a cell and provides an advantage over using the actives alone. The method includes contacting cells with test agents, alone and in combination, and determining a response of the cells to the test agent(s), wherein the response corresponds to a change in a metabolic indicator associated with glycolysis and a change in a metabolic indicator associated with oxidative phosphylation.
    Type: Grant
    Filed: October 9, 2013
    Date of Patent: August 8, 2017
    Assignee: The Procter & Gamble Company
    Inventors: John Erich Oblong, Holly Ann Rovito
  • Publication number: 20170196795
    Abstract: Cosmetic methods and compositions for improving the appearance and barrier function of skin. The methods and compositions utilize a combination of niacinamide and a suitable saccharide at low pH to decrease trans-epidermal water loss in skin, reduce the size of hyperpigmented spots, and improve the appearance of skin better than their high pH counterparts.
    Type: Application
    Filed: January 10, 2017
    Publication date: July 13, 2017
    Inventors: Tomohiro HAKOZAKI, John Erich OBLONG
  • Publication number: 20160374908
    Abstract: A stable cosmetic agent in the form of a plurality of encapsulated particles in a core-shell configuration. The encapsulated particles are formed by coating nicotinamide riboside powder or a nicotinamide riboside containing material with one or more water-insoluble encapsulating agents. The stable encapsulated nicotinamide riboside particles exhibit less than 20% hydrolysis when incorporated into an aqueous skin care composition.
    Type: Application
    Filed: June 29, 2016
    Publication date: December 29, 2016
    Inventors: Tomohiro HAKOZAKI, John Erich OBLONG, Jesus VELAZQUEZ, Jiten Odhavji DIHORA
  • Publication number: 20160374919
    Abstract: A skin care product is provided. The skin care product includes a multi-component skin care composition disposed in a multi-chamber container. The multi-component skin care composition includes an aqueous carrier component and a nicotinamide riboside component disposed in separate chambers, which prevents these components from contacting one another prior to use. The aqueous carrier component and the nicotinamide riboside component can be separated from one another by one or more fluid impermeable dividing members and/or activatable elements, which upon activation enable contact between the aqueous carrier component and nicotinamide riboside component.
    Type: Application
    Filed: June 29, 2016
    Publication date: December 29, 2016
    Inventors: Tomohiro HAKOZAKI, John Erich OBLONG, Jesus VELAZQUEZ
  • Publication number: 20160317419
    Abstract: Cosmetic methods of increasing ARE activated gene transcription in a skin cell by contacting skin cells in a target portion of skin with an effective amount of niacinamide and nicotinamide riboside in combination to increase ARE activated gene transcription or synergistically increase ARE activated gene transcription of at least some of the skin cells contacted with the niacinamide and nicotinamide riboside. The cosmetic methods also enable synergistic reduction of ROS-induced adenosine triphosphate (ATP) depletion in a skin cell and restoration of glycolytic ATP production rate in a skin cell that has been reduced as a result of ROS-induced oxidative stress.
    Type: Application
    Filed: April 29, 2016
    Publication date: November 3, 2016
    Inventors: Tomohiro HAKAZAKI, Leo Timothy LAUGHLIN, II, John Erich OBLONG, Jesus VELAZQUEZ
  • Publication number: 20160317418
    Abstract: A cosmetic method for reducing the level of High-Mobility Group Protein B1 released from keratinocytes. The method includes identifying a target portion of skin where reduction of HMGB1 level is desired, and topically applying a nicotinamide riboside containing cosmetic composition to the target portion of skin during a treatment period, which is sufficient to reduce the level of HMGB1 released by keratinocytes. By reducing HMGB1 protein level, melanocyte dendricity can be reduced, thereby resulting in less melanin being taken into keratinocytes. The reduction in melanin transfer may provide a way to treat skin pigmentation disorders such as hyperpigmented spots.
    Type: Application
    Filed: April 29, 2016
    Publication date: November 3, 2016
    Inventors: Tomohiro HAKAZAKI, Leo Timothy LAUGHLIN, II, John Erich OBLONG
  • Publication number: 20150316537
    Abstract: A method of identifying or evaluating synergistic combinations of actives such as skin-care actives that improve the metabolism of a cell and provides an advantage over using the actives alone. The method includes contacting cells with test agents, alone and in combination, and determining a response of the cells to the test agent(s), wherein the response corresponds to a change in a metabolic indicator associated with glycolysis and a change in a metabolic indicator associated with oxidative phosphylation.
    Type: Application
    Filed: October 9, 2013
    Publication date: November 5, 2015
    Applicant: The Procter & Gamble Company
    Inventors: John Erich OBLONG, Holly Ann ROVITO
  • Publication number: 20150276714
    Abstract: A method of identifying or evaluating skin-care actives that improve the metabolism of a skin cell. The method includes contacting cells with a stressor and a test agent and determining a response of the cells to the stressor and test agent, based on the change in metabolic indicators associated with glycolysis and/or oxidative phosphylation. The test agent may be identified as a skin-care active when the oxidative phosphorylation and/or glycolysis response corresponds to an improvement in cellular metabolism.
    Type: Application
    Filed: October 9, 2013
    Publication date: October 1, 2015
    Applicant: The Procter & Gamble Company
    Inventors: John Erich OBLONG, Holly Ann ROVITO
  • Patent number: 9144538
    Abstract: Cosmetic compositions for alleviating the signs of photoaged skin containing a substituted azole. Methods for alleviating the signs of photoaged skin that include applying a cosmetic composition comprising substituted azole to a target UV-exposed skin surface. The substituted azole compound present in the cosmetic composition may be 1-phenylimidazole, 4-phenylimidazole or a combination thereof. An effective amount of the cosmetic composition is applied to the target skin surface for a period of time sufficient to alleviate at least one sign of photoaging.
    Type: Grant
    Filed: January 29, 2014
    Date of Patent: September 29, 2015
    Assignee: The Procter & Gamble Company
    Inventors: Supriya Punyani Bareja, Stevan David Jones, John Erich Oblong, Kevin John Mills, John Crist Bierman
  • Patent number: 9138393
    Abstract: Methods of improving the appearance of aging skin that include applying a cosmetic composition to a target skin surface having one or more signs of aging. The cosmetic composition includes a substituted azole. In some instances, the substituted azole compound is 1-phenylimidazole, 4-phenylimidazole, or combinations thereof. An effective amount of the cosmetic composition is applied for a period of time sufficient to improve the appearance of at least one sign of aging skin.
    Type: Grant
    Filed: January 29, 2014
    Date of Patent: September 22, 2015
    Assignee: The Procter & Gamble Company
    Inventors: Supriya Punyani Bareja, Stevan David Jones, John Erich Oblong, Kevin John Mills, John Crist Bierman